This chapter about the recognition, treatment, and prevention of heparin-induced
thrombocytopenia (HIT) is part of the Seventh ACCP Conference on Antithrombotic and …

Review Page 1 Review HEPARIN-INDUCED THROMBOCYTOPENIA: PATHOGENESIS AND
MANAGEMENT Heparin-induced thrombocytopenia (HIT) is a transient prothrombotic disorder …

Immunoassays are essential in the workup of patients with suspected heparin-induced
thrombocytopenia. However, the diagnostic accuracy is uncertain with regard to different …

Introduction: Platelet‐activating antiplatelet factor 4/heparin (anti‐PF4/heparin) antibodies
are the major cause of heparin‐induced thrombocytopenia (HIT). However, the relative utility …

Acquired abnormalities in platelets, endothelium, and their interaction occur in sepsis,
immune heparin-induced thrombocytopenia (HIT), and the antiphospholipid syndrome …

Background: Heparin‐induced thrombocytopenia (HIT) is a severe disease that is often
difficult to diagnose. A clinical scoring system, the '4Ts' score, has been proposed to …

Thrombocytopenia is an often faced problem in the emergency department (ED) that can
signal a life-threatening condition. This situation may be a patient's first presentation of a …

Background Diagnosing heparin-induced thrombocytopenia (HIT) at the bedside remains
challenging, exposing a significant number of patients at risk of delayed diagnosis or …

Heparin‐induced thrombocytopenia (HIT) occurs in nearly 3% of patients treated with
heparin after cardiopulmonary bypass (CPB). HIT carries a risk of severe thrombotic …

Background: Heparin‐induced thrombocytopenia (HIT) is usually caused by anti‐platelet
factor 4 (PF4)/heparin antibodies, leading to intravascular platelet activation. These …